BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 956340)

  • 1. Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis.
    Goldsmith RS; Jowsey J; Dubé WJ; Riggs BL; Arnaud CD; Kelly PJ
    J Clin Endocrinol Metab; 1976 Sep; 43(3):523-32. PubMed ID: 956340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Am J Clin Nutr; 1984 Jun; 39(6):857-9. PubMed ID: 6720619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis.
    Jowsey J; Riggs BL; Goldsmith RS; Kelly PJ; Arnaud CD
    J Clin Endocrinol Metab; 1971 Nov; 33(5):752-8. PubMed ID: 4942159
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of calcium supplementation on bone loss in postmenopausal women.
    Reid IR; Ames RW; Evans MC; Gamble GD; Sharpe SJ
    N Engl J Med; 1993 Feb; 328(7):460-4. PubMed ID: 8421475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sex hormones on bone in primary osteoporosis.
    Riggs BL; Jowsey J; Kelly PJ; Jones JD; Maher FT
    J Clin Invest; 1969 Jun; 48(6):1065-72. PubMed ID: 5771187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical effects of calcium supplementation in postmenopausal osteoporosis.
    Horowitz M; Need AG; Morris HA; Wishart J; Nordin BE
    Eur J Clin Nutr; 1988 Sep; 42(9):775-8. PubMed ID: 3181110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest.
    Hulley SB; Vogel JM; Donaldson CL; Bayers JH; Friedman RJ; Rosen SN
    J Clin Invest; 1971 Dec; 50(12):2506-18. PubMed ID: 5129304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
    Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
    Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory tests and bone biopsy in the diagnosis and treatment of osteoporosis].
    Burckhardt P
    Rev Med Suisse Romande; 1982 Jun; 102(6):599-605. PubMed ID: 7134717
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
    Gallagher JC; Riggs BL; DeLuca HF
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal estradiol in the treatment of postmenopausal bone loss.
    Adami S; Suppi R; Bertoldo F; Rossini M; Residori M; Maresca V; Lo Cascio V
    Bone Miner; 1989 Aug; 7(1):79-86. PubMed ID: 2670019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. I: Chemical quantities in serum and urine.
    Mosekilde L; Christensen MS; Melsen F; Sørensen NS
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):743-50. PubMed ID: 580520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of different phosphorus sources on calcium and bone metabolism in young women: a whole-foods approach.
    Karp HJ; Vaihia KP; Kärkkäinen MU; Niemistö MJ; Lamberg-Allardt CJ
    Calcif Tissue Int; 2007 Apr; 80(4):251-8. PubMed ID: 17401693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluoride therapy on nondialyzable urinary hydroxyproline, serum alkaline phosphatase, parathyroid hormone, and 25-hydroxyvitamin D.
    Manzke E; Rawley R; Vose G; Roginsky M; Rader JI; Baylink DJ
    Metabolism; 1977 Sep; 26(9):1005-10. PubMed ID: 895531
    [No Abstract]   [Full Text] [Related]  

  • 20. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.
    Riggs BL; Jowsey J; Goldsmith RS; Kelly PJ; Hoffman DL; Arnaud CD
    J Clin Invest; 1972 Jul; 51(7):1659-63. PubMed ID: 4338118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.